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Aldosterone measurement in cell culture medium
To measure aldosterone secretion in the medium HAC15 cells were treated with 10-7 M angiotensin II (Ang II, Sigma-Aldrich, Milan, Italy) or 10-8 M 17-estradiol (E2, Sigma-Aldrich, Milan, Italy).  HAC15 cells were also treated with E2 on top of 10-5 M MPP (1,3-Bis (4-hydroxyphenyl) - 4-methyl- 5- [4- (2-piperidinylethoxy)phenol]- 1H-pyrazole-dihydrochloride; Sigma-Aldrich, Milan, Italy), a selective ERα antagonist, plus 10-5 M THC ((R,R)-5,11-Diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol; Tocris Biosciences, Bristol, UK), a selective ERβ antagonist.  Cell culture medium was collected after 24 hours of stimulation.
Aldosterone levels were quantified with the Aldosterone Elisa kit (Alpha Diagnostic International, Chimici Italiani, Rome, Italy) following the manufacturer’s protocol.  Aldosterone levels were normalized to the amount of cell RNA content.
Cell viability assay
Cell viability after treatment with increasing concentration of canrenone (10-9 M to 10-3 M) was measured with the colorimetric assay system methyl-thiazol-etetrazolium (MTT) (Sigma, Milan, Italy) following the manufacturer’s protocol.  Briefly, 50000 HAC15 cells were treated for 24 hours with the different concentrations of canrenone in 96-well plates.  After treatment, 25 μL of the MTT solution was added to each well of 96-well plates and incubated for 4 h at 37 °C.  At the end of the incubation period, the absorbance was determined at 570 nm. 
GPER and AT1R receptor gene expression 
GPER and AT1R mRNAs in aldosterone producing adenoma (APA) and in APA adjacent tissue were measured with Droplet Digital PCR (ddPCR, Bio-Rad, Milan, Italy).  RNA extraction and retrotranscription reaction were performed as previously described.  DdPCR was carried out using the ddPCR™ Supermix for Probes (No dUTP) (Bio-Rad, Milan, Italy), the QX200™ Droplet Generator (Bio-Rad, Milan, Italy) and the QX200 Droplet Reader (Bio-Rad, Milan, Italy), following manufacturer’s instructions.  Reactions were set up using 10 ul/reaction of 2x ddPCR Supermix for Probes (No dUTP), 200 nM of primers and probe for GPER or AT1R, 2 l of cDNA and 7.4 l H2O in a 96 well plate.  The reaction mixture was transferred to DG8™ Cartridge for QX200/QX100 Droplet Generator (Bio-Rad, Milan, Italy) followed by 70 μl of Droplet Generation Oil for Probes (Bio-Rad, Milan, Italy), according to the QX200 Droplet Generator Instruction Manual (Bio-Rad, Milan, Italy).  After droplet generation, 40 l of the reaction were transferred to PCR plate and PCR reactions were carried out in the thermocycler using the following parameters: Step 1) 95 °C for 10 min, Step 2) 94 °C for 30 s and 60 °C for 1 min (Step 2 was repeat 39 times), Step 3) 98 °C for 10 min and Step 4) 4 °C infinite hold. The reactions were read in the QX200 Droplet Reader and the RNA targets were quantified using the QuantaSoft™ Software (Bio-Rad, Milan, Italy).  Absolute levels of the gene target were expressed as number of copies per g of RNA.  GPER and AT1R primers used in ddPCR are reported in Supplemental Table 1.
Co-immunoprecipitation (Co-IP) studies 
Co-IP procedures were performed at 4°C unless otherwise indicated, using Pierce® Crosslink Immunoprecipitation Kit (ThermoScientific, Milan, Italy).  Protein A/G agarose resin (20 µl) was washed twice with 200 µl PBS buffer, and incubated with 10 µg of anti-GPER (Novus biologicals, Milan, Italy) or anti-AT1R (Cusabio, Paris, France) antibody prepared in coupling buffer at room temperature (RT) for 1 hour on a mixer.  In parallel, anti-rabbit IgG secondary antibody was similarly prepared as the negative control.  Then the supernatant was discarded and the A/G agarose resin was washed three times with 300 μL of coupling buffer, followed by incubation with 50 l of DSS solution (disuccinimidyl suberate dissolved in DMSO) at RT for 1 hour on a mixer.  This step allowed to covalently bind GPER or AT1R antibodies to Protein A/G agarose resin to avoid antibody contamination during antigen elution.  The A/G agarose resin was washed twice with 100 μL of Elution Buffer to remove non-crosslinked antibody, then once with IP Lysis/Wash Buffer.  The GPER-crosslinked agarose resin or AT1R-crosslinked agarose resin were incubated overnight at 4°C with 500 g lysate of HAC15 cells that were pre-cleared with control agarose resin.  After removing supernatant (flow-through) and washing with IP Lysis/Wash buffer 5 times, the immunoprecipitates were eluted and analyzed by western blot.  We investigated the presence of AT1R In immunoprecipitates obtained from GPER-cross-linked agarose resin and analyzed GPER expression in immunoprecipitates from AT1R-crosslinked agarose resin. 
Results
Angiotensin II and 17-estradiol treatment enhances CYP11B2 
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Legends to the figures
Supplemental Figure 1: Canrenone and RU486 treatments did not blunt the effect of aldosterone on CYP11B2.  Panel A: CYP11B2 gene expression after exposure of HAC15 cells to increasing concentration of canrenone.  Canrenone stimulated aldosterone synthase starting at 10-6 and up to 10-4 M, but it significantly decreased CYP11B2 gene expression at 10-3 M. Data represent mean ± SD (n= 5).  Panel B: Effects of canrenone on HAC15 cell viability.  HAC15 cell exposed for 48 hours to increasing concentration of canrenone. The MTT test revealed that canrenone caused a significant reduction of HAC15 cells viability at 10-3 M concentration. Data represent mean ± SD (n= 5).  Panel C:  CYP11B2 gene expression after treatment of HAC15 cells with aldosterone 10-7 M on top of RU486 10-6 M or 10-5 M.  Data represent median and 95% CI of 3 different experiments performed in duplicate. 
* P < 0.01; ** P < 0.001.
Supplemental Figure 2: Exposure of HAC15 cells to Ang II and E2, alone or on top of ER antagonist (MPP) and ERβ antagonist (THC), resulted in increased CYP11B2 gene expression (Panel A).  This increased gene expression was consistent with increased aldosterone release in the medium (Panel B). Data represent mean ± SD (n= 3).
* P < 0.01; ** P < 0.001.
Supplemental Figure 3: Gene expression of GPER and AT1R in human adrenal tissue. Panel A: Absolute amount of GPER and AT1R in APA- adjacent tissue, (n=5) and in APA tissues (n=5).  Panel B: GPER and AT1R protein expression in APA- adjacent tissue (n=5) and in APA tissues (n=5). 
* P < 0.03; ** P < 0.001
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